Position in NVS
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$138,540
+$11,605 QoQ
Shares Held
884
+6.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,348
of 1,603 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 37%
Shared 0%
None 63%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOMPKINS FINANCIAL CORP holds $81,349,193 across 13 Drug Manufacturers - General names. NVS ranks #11 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,597 | $33,100,672 | |
| 2 | AMGN |
Amgen Inc
|
46,212 | $16,734,289 | |
| 3 | MRK |
Merck & Co., Inc.
|
93,472 | $12,011,152 | |
| 4 | ABBV |
AbbVie Inc.
|
35,368 | $8,900,003 | |
| 5 | JNJ |
Johnson & Johnson
|
30,781 | $7,817,450 | |
| 6 | PFE |
Pfizer Inc
|
55,818 | $1,344,097 | |
| 7 | BIIB |
Biogen Inc.
|
2,200 | $475,332 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,254 | $284,770 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $138,540 | 884 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $126,935 | 831 | Shares | Defined | 2026-04-09 | |
| 2025-12-31 | $77,207 | 560 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $71,814 | 560 | Shares | Defined | 2025-10-08 | |
| 2025-06-30 | $219,028 | 1,810 | Shares | Defined | 2025-07-10 | |
| 2025-03-31 | $324,406 | 2,910 | Shares | Defined | 2025-04-07 | |
| 2024-12-31 | $283,172 | 2,910 | Shares | Defined | 2025-01-15 | |
| 2024-09-30 | $334,708 | 2,910 | Shares | Defined | 2024-11-01 | |
| 2024-06-30 | $309,798 | 2,910 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $287,577 | 2,973 | Shares | Defined | 2024-04-08 | |
| 2023-12-31 | $233,240 | 2,310 | Shares | Defined | 2024-01-08 | |
| 2023-09-30 | $235,296 | 2,310 | Shares | Defined | 2023-11-21 | |
| 2023-06-30 | $233,102 | 2,310 | Shares | Defined | 2023-07-12 | |
| 2023-03-31 | $243,248 | 2,644 | Shares | Defined | 2023-04-20 | |
| 2022-12-31 | $244,399 | 2,694 | Shares | Defined | 2023-01-06 | |
| 2022-09-30 | $204,770 | 2,694 | Shares | Defined | 2022-10-13 | |
| 2022-06-30 | $227,723 | 2,694 | Shares | Defined | 2022-07-14 | |
| 2022-03-31 | $277,202 | 3,159 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $227,334 | 2,599 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $212,546 | 2,599 | Shares | Sole | 2021-10-22 | |
| 2021-03-31 | $272,253 | 3,185 | Shares | Sole | 2021-06-09 | |
| 2020-12-31 | $313,885 | 3,324 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $285,663 | 3,285 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $286,911 | 3,285 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $270,848 | 3,285 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||